pamidronate has been researched along with Beuren Syndrome in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome." | 7.88 | Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome. ( Baş, VN; Baştuğ, F; Çetinkaya, H; Nalçacıoğlu, H; Tekatlı-Çelik, B; Yel, S, 2018) |
| "To report the efficacy of Pamidronate to treat hypercalcaemia in a patient with Williams-Beuren syndrome (WBS)." | 7.72 | Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate). ( Gravano, JC; Mastaglia, SR; Mautalen, C; Oliveri, B; Pardo Argerich, L, 2004) |
| " Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome." | 3.88 | Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome. ( Baş, VN; Baştuğ, F; Çetinkaya, H; Nalçacıoğlu, H; Tekatlı-Çelik, B; Yel, S, 2018) |
| "To report the efficacy of Pamidronate to treat hypercalcaemia in a patient with Williams-Beuren syndrome (WBS)." | 3.72 | Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate). ( Gravano, JC; Mastaglia, SR; Mautalen, C; Oliveri, B; Pardo Argerich, L, 2004) |
| "Williams-Beuren syndrome (WBS) is a rare genetic disorder caused by the deletion of 26-28 genes on chromosome 7." | 2.50 | Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome. ( Geesing, CL; Hoenderop, JG; Lameris, AL; Schreuder, MF, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baştuğ, F | 1 |
| Nalçacıoğlu, H | 1 |
| Baş, VN | 1 |
| Tekatlı-Çelik, B | 1 |
| Çetinkaya, H | 1 |
| Yel, S | 1 |
| Lameris, AL | 1 |
| Geesing, CL | 1 |
| Hoenderop, JG | 1 |
| Schreuder, MF | 1 |
| Ismail, J | 1 |
| Sangun, O | 1 |
| Dundar, BN | 1 |
| Erdogan, E | 1 |
| Oliveri, B | 1 |
| Mastaglia, SR | 1 |
| Mautalen, C | 1 |
| Gravano, JC | 1 |
| Pardo Argerich, L | 1 |
| Cagle, AP | 1 |
| Waguespack, SG | 1 |
| Buckingham, BA | 1 |
| Shankar, RR | 1 |
| Dimeglio, LA | 1 |
1 review available for pamidronate and Beuren Syndrome
| Article | Year |
|---|---|
Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome.
Topics: Calcitriol; Calcium, Dietary; Child, Preschool; Diphosphonates; Female; Gene Deletion; Humans; Hyper | 2014 |
5 other studies available for pamidronate and Beuren Syndrome
| Article | Year |
|---|---|
Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome.
Topics: Acute Kidney Injury; Bone Density Conservation Agents; Female; Humans; Hypercalcemia; In Situ Hybrid | 2018 |
Pamidronate for long-term control of hypercalcemia associated with Williams syndrome.
Topics: Child, Preschool; Diphosphonates; Humans; Hypercalcemia; Male; Pamidronate; Williams Syndrome | 2015 |
Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.
Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hypercalcemia; Infant; Infusion Pu | 2011 |
Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
Topics: Anti-Inflammatory Agents; Calcium; Diphosphonates; Follow-Up Studies; Humans; Hypercalcemia; Infant; | 2004 |
Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
Topics: Calcium, Dietary; Diphosphonates; Female; Humans; Hypercalcemia; Infant; Infusions, Intravenous; Mal | 2004 |